NEW YORK (TheStreet) -- CHANGE IN RATINGS

Palm

(PALM)

upgraded at Barclays to Equal Weight from Underweight on limited downside. Price target cut to $11 from $12. 2010 and 2011 EPS estimates set at -$0.26 and $0.29, respectively.

Molson Coors

(TAP) - Get Report

downgraded at Goldman from Buy to Neutral. Despite low valuation, see limited upside potential, as volume trends are weak. $53 price target.

Terex

(TEX) - Get Report

downgraded at Morgan Stanley from Equal-weight to Underweight. $18 price target. Company faces more headwinds than its peers, and will likely be later to recover.

STOCK COMMENTS / EPS CHANGES

Automatic Data

(ADP) - Get Report

estimates increased at Goldman through 2012. Company is realizing higher operating margins. Neutral rating and $43 price target.

Agrium

(AGU)

estimates, target cut at UBS. Shares of AGU now seen reaching $50. Estimates also lowered, to reflect a late planting season and lower price expectations. Neutral rating.

Allstate

(ALL) - Get Report

estimates boosted at UBS through 2010. Sales have stabilized, and auto profitability is rising. Neutral rating and $31.50 price target.

Applied Materials

(AMAT) - Get Report

estimates boosted at UBS through 2010. Company likely seeing higher silicon orders from Taiwan. Buy rating and $17 price target.

Alpha Natural

(ANR)

numbers boosted at FBR. Shares of ANR now seen reaching $54. Estimates also raised, to reflect higher met coal volumes. Outperform rating.

Baker Hughes

(BHI)

estimates lowered at Goldman through 2011. Company is seeing lower international margins.

Bucyrus

(BUCY)

estimates raised at Goldman through 2011. Visibility is improving for new equipment production. Buy rating and $62 price target.

Career Education

(CECO) - Get Report

estimates boosted at UBS through 2010. Company is seeing higher revenue per enrollment. Buy rating and $30 price target.

Commercial Metals

(CMC) - Get Report

numbers lowered at Goldman through 2011. Mill margins are eroding and trading profits remain under pressure. Neutral rating and new $16 price target.

Comcast

(CMCSA) - Get Report

estimates raised at Goldman through 2011. Company is seeing better subscriber growth. Buy rating and $18 price target.

Charles River Labs

(CRL) - Get Report

numbers cut at Goldman through 2012. Pre-clinical demand remains weak. Neutral rating and new $35 price target.

Cisco Systems

(CSCO) - Get Report

numbers raised at Goldman. Shares of CSCO now seen reaching $26. Estimates also boosted, to reflect a recovery in enterprise spending. Neutral rating.

Amdocs

(DOX) - Get Report

estimates, target boosted at Goldman. Shares of DOX now seen reaching $28. Estimates also raised, to reflect higher realized margins. Neutral rating.

Devon Energy

(DVN) - Get Report

price target, estimates raised at Barclays. Barclays increased DVN price target to $78 from $64 on higher 4Q volume guidance. 2009 and 2010 EPS estimates raised to $3.55 and $6.15, respectively. Maintain Equal Weight rating.

Devon

(DVN) - Get Report

estimates raised at Goldman through 2011. Company is seeing higher production rates and lower realized costs. Buy rating and $90 price target.

Fortune Brands

(FO)

initiated at BofA/Merrill with a Neutral rating and $43 price target. Slow recovery in home and consumer spending. 2009 and 2010 EPS estimates set at $2.28 and $2.79, respectively.

Foster Wheeler

(FWLT)

price target, estimates higher at Barclays. Raised FWLT price target to $41 from $37 on solid 3Q results. Maintain Overweight rating. 2009 and 2010 EPS estimates lifted to $2.99 and $2.55.

Garmin

(GRMN) - Get Report

estimates boosted at Goldman through 2011. Company is seeing higher margins, but smartphones are starting to cannibalize the business. Sell rating and $26 price target.

Microchip

(MCHP) - Get Report

estimates, target boosted at Goldman. Shares of MCHP now seen reaching $22. Estimates also raised, to reflect a higher sales outlook and cost cutting. Sell rating.

Mercadolibre

(MELI) - Get Report

estimates boosted at Morgan Stanley through 2011. Company is realizing higher sales growth. Equal-weight rating.

News Corp.

(NWSA) - Get Report

estimates raised at UBS through 2011. Broadcast and cable ad trends are improving. Neutral rating and $12 price target.

News Corp.

(NWSA) - Get Report

price target, estimates raised at Barclays. NWSA price target increased to $14 from $12. 2010 EPS estimate lifted by 3 cents to $0.81, 2011 introduced at $1.05. Maintain Equal Weight rating.

Oil States Int'l.

(OIS) - Get Report

numbers boosted at Goldman. Shares of OIS now seen reaching $41. Estimates also raised, as the company is seeing better offshore and tubular margins. Neutral rating.

ON Semiconductor

(ONNN)

estimates increased at UBS through 2010. Company is seeing higher margins and using cash flow to pay down debt. Buy rating and $12 price target.

Qualcomm

(QCOM) - Get Report

estimates, target lowered at FBR. Shares of QCOM now seen reaching $48. Estimates also reduced, to match the company's new guidance. Outperform rating.

Transocean

(RIG) - Get Report

estimates lowered at Goldman through 2011. Company is facing higher interest expenses, but still has attractive deepwater assets. Buy rating and $111 price target.

Tyco Electronics

(TEL) - Get Report

numbers increased at UBS. Shares of TEL now seen reaching $27. Estimates also boosted, to reflect higher realized operating margins. Buy rating.

Tenet Healthcare

(THC) - Get Report

estimates increased at UBS through 2010. Company raised sales guidance and is keeping a tight lid on costs. Neutral rating and $6 price target.

TRW Automotive

(TRW)

numbers boosted at Goldman. Shares of TRW now seen reaching $24. Estimates also increased, to reflect higher realized sales and margins. Neutral rating.

Time Warner

(TWX)

price target, estimates higher at Barclays. TWX price target inflated by a dollar to $31. 2009 and 2010 EPS estimates raised to $2.09 and $2.25, respectively. Maintain Equal Weight rating.

Time Warner

(TWX)

estimates boosted at Goldman through 2010. Company is seeing better content results. Buy rating and $36 price target.

Varian

(VARI)

estimates lowered at UBS through 2010. Company is seeing lower sales of scientific instruments and has limited forward visibility. Neutral rating and $52 price target.

Wellcare

(WCG) - Get Report

estimates lowered at Goldman through 2011. Company seeing lower enrollment rates. Buy rating and $34 price target.

Whole Foods

(WFMI)

estimates raised at Morgan Stanley through 2012. Company is realizing better margins across the board. Equal-weight rating.

XTO

(XTO)

price target, estimates boosted at Barclays. XTO price target surged to $57 from $47 on strong growth prospects. 2009 and 2010 EPS estimates each raised by 5 cents to $3.55 and $1.70, respectively. Reiterate Overweight rating.

This article was written by a staff member of TheStreet.com.